Ochsner is piloting a genetic screening program that tests for common hereditary cancers and heart disease. This voluntary program is part of Ochsner’s commitment to using cutting-edge technology to improve patient outcomes through early detection and prevention.
Nearly 2 million people in the United States are at an increased risk for early-onset cancer or heart disease because they have one of the following genetic conditions: Hereditary Breast and Ovarian Cancer Syndrome, Lynch Syndrome or Familial Hypercholesterolemia.
Many individuals and families with these conditions are not aware they are at risk. Importantly, for individuals that test positive for one of these conditions, there are clear steps that can be followed by healthcare providers to prevent premature disease and death.
What we screen for
The pilot phase of this program will screen for 3 conditions. The Centers for Disease Control (CDC) created a grouping of hereditary conditions that have two requirements:
- These conditions increase the risk of disease (cancer or heart disease).
- Early detection and management can, in most cases, reduce or eliminate the risk associated with the disease.
These conditions are:
Hereditary Breast and Ovarian Cancer Syndrome (HBOC), which increases the risk for breast, ovarian, tubal, peritoneal and other cancers due to mutations in BRCA1 or BRCA2 genes.
Familial Hypercholesterolemia (FH), which increases the risk for heart disease or stroke due to mutations leading to very high cholesterol levels from an early age.
Lynch Syndrome (LS), which increases the risk for colorectal, endometrial, ovarian and other cancers associated with mutations in mismatch-repair genes.
Find out if you are at an increased risk of developing certain hereditary cancers and heart disease. Ochsner has partnered with the nationally-recognized genetic sequencing company, Color, to provide the latest in clinical-grade, genetic-testing technology.
If your results show you are at an increased risk, work with genetic counselors and healthcare providers to begin screening and treatment options as early as possible.
Understand how your risk can impact your family and help them get screened too.
Your test results are available to you and your care team in Ochsner’s electronic health record (MyOchsner) to use in treatment recommendation and adjustments, if needed.
Your test results and genetic data are kept secure in Ochsner’s data management system and will not be shared without your consent.
Interested in Ochsner's genetic screening pilot?
This program is currently in its pilot phase and is available on a limited basis. Check your MyOchsner messages to see if you qualify.